HIV Snippets: A Podcast Series

1.25 CPE
1.25 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Image of red blood cells


Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Activity Description

Antiretroviral therapy (ART) for treating HIV has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of 4 podcasts. The faculty will explore various aspects of HIV management, including recent advances in pre-exposure prophylaxis (PrEP), use of 3-drug versus 2-drug regimens, individualizing ART regimens in aging patients with HIV, as well as the management of patients with HIV who struggle with stigma and/or adherence.

Target Audience

The intended audience for this activity is infectious disease specialists, internists, pharmacists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with or at risk for HIV.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Explore how pre-exposure prophylaxis (PrEP) for HIV can successfully be implemented into clinical practice using an interprofessional approach.
  • Assess the latest evidence regarding the selection of antiretroviral regimens in aging patients with HIV.
  • Recognize the need for antiretroviral treatment regimens that improve patient adherence to therapy.
  • Compare the use of 3-drug versus 2-drug antiretroviral regimens in terms of efficacy, safety, and meeting the needs of individual patients with HIV.

Activity Chair

Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Investigator, Lundquist Institute
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA


Melissa E. Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP
Clinical Associate Professor
Section of Infectious Diseases Pharmacotherapy
Department of Pharmacy Practice
University of Illinois at Chicago, College of Pharmacy
Chicago, IL

Meredith E. Clement, MD
Assistant Professor
Infectious Diseases
Louisiana State University Health Sciences Center
New Orleans, LA

Joseph J. Eron, Jr., MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC

Chloe Orkin, MBBCh, FRCP
Consultant Physician, Barts Health NHS Trust
Clinical Lead for COVID 19 Research at Barts Health NHS Trust
Lead for HIV and HIV/Hep C Research
Athena Swan Chair, Queen Mary, University of London School of Medicine
London, United Kingdom


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Jennifer Frederick, PharmD, BCPS


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is acceptable for 1.25 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-22-014-H02-P, effective 6/15/2022. This is a knowledge-based activity and there is no fee to attend.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.25 hours credit for completing this program.

abimSuccessful completion of this CME activity enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, June 15, 2022, to June 14, 2023.

How to Participate in This Activity and Obtain CE Credit

To participate in this CE activity, you must read the objectives, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 6 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or Statement of Continuing Pharmacy Education Credit.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.


Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant relationship(s)

Melissa E. Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP
No relevant financial relationships to disclose.

Meredith E. Clement, MD
Advisor: Roche, ViiV
Independent Research Contractor (paid to institution): Gilead, Janssen, ViiV

Eric S. Daar, MD
Consultant: Gilead, GlaxoSmithKline/ViiV, Merck
Independent Research Contractor: Gilead, GlaxoSmithKline/ViiV, Merck

Joseph J. Eron, Jr., MD
Consultant: Gilead, Merck, ViiV
Independent Research Contractor: Gilead, Janssen, ViiV

Chloe Orkin, MBBCh, FRCP
Advisor: Gilead, GlaxoSmithKline, Janssen, Merck, ViiV
Speaker Contracted by Ineligible Company: Gilead, GlaxoSmithKline, Janssen, Merck, ViiV
Independent Research Contractor: Gilead, GlaxoSmithKline, Janssen, Merck, ViiV

Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to Requests will be honored within 3-5 business days.

CE Questions?

Contact us at